Case 3. Fluorouracil-induced exacerbation of systemic lupus erythematosus

Journal of Clinical Oncology

Volumn 20, Issue 13, 2002, Pages 3032-3034

  Moazzam, Nauman ^a   Malik, Ashar A ^a   Mehdi, Syed A ^a   Potti, Anil ^a  

^a UND School of Medicine & Health Sciences Southeast Campus   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; ANTINEOPLASTIC ANTIMETABOLITE;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CASE REPORT; COLON CANCER; DISEASE EXACERBATION; DRUG METABOLISM; HUMAN; MALE; PRIORITY JOURNAL; RASH; SKIN BIOPSY; SYSTEMIC LUPUS ERYTHEMATOSUS; ACUTE DISEASE; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE;

ACUTE DISEASE; ANTIMETABOLITES, ANTINEOPLASTIC; FLUOROURACIL; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RECURRENCE;

EID: 0036634847     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.2002.20.13.3032     Document Type: Article

References (8)

1. Efficacy of adjuvant fluorouracil and leucovorin in stage B2 and C colon cancer: International Multicenter Pooled Analysis of Colon Cancer Trials Investigators
2. Fluorouracil and new oral fluorinated pyrimidines
3. Acute toxicities of chemotherapy
4. 5-Flurouracil induced small bowl toxicity in patients with colorectal carcinoma
5. Photosensitivity due to a fluorouracil derivative
6. Erythema with features of seborrheic dermatitis and lupus erythematosus associated with 5-fluorouracil
7. Discoid lupus erythematosus (DLE)-like lesions induced by uracil-tegafur (UFT)
8. Immunosuppressive drug therapy for rheumatic disease